Xeris Biopharma Holdings Gross Profit (Quarterly) Insights

Xeris Biopharma Holdings Inc (XERS)

2.87 +0.04 (+1.41%) USD | NASDAQ | Sep 27, 16:00

2.87 0.00 (0.00%) After-Hours: 20:00

Gross Profit (Quarterly) Chart

Historical Gross Profit (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	40.28M
March 31, 2024	34.67M
December 31, 2023	36.82M
September 30, 2023	40.12M
June 30, 2023	30.45M
March 31, 2023	27.88M
December 31, 2022	26.85M
September 30, 2022	24.46M
June 30, 2022	20.50M
March 31, 2022	15.80M
December 31, 2021	16.54M
September 30, 2021	7.84M
June 30, 2021	5.523M
March 31, 2021	6.369M
December 31, 2020	3.962M

Date	Value
September 30, 2020	6.572M
June 30, 2020	0.728M
March 31, 2020	-0.114M
December 31, 2019	0.261M
September 30, 2019	0.313M
June 30, 2019	0.297M
March 31, 2019	0.248M
December 31, 2018	0.801M
September 30, 2018	0.582M
June 30, 2018	0.819M
March 31, 2018	0.221M
December 31, 2017	0.467M
September 30, 2017	0.17M
June 30, 2017	0.561M
March 31, 2017	0.354M

Gross Profit Definition

Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.

Read full definition.

Gross Profit (Quarterly) Range, Past 5 Years

-0.114M

Minimum

Mar 2020

40.28M

Maximum

Jun 2024

17.29M

Average

16.17M

Median

Gross Profit (Quarterly) Benchmarks